Imperva, Inc. (IMPV) Receives Consensus Recommendation of “Hold” from Analysts

Imperva, Inc. (NASDAQ:IMPV) has been assigned an average rating of “Hold” from the twenty analysts that are presently covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company. The average 1 year price target among brokerages that have covered the stock in the last year is $52.38.

IMPV has been the subject of several research analyst reports. Evercore ISI set a $56.00 price objective on shares of Imperva and gave the company a “buy” rating in a research report on Thursday, August 10th. Monness Crespi & Hardt raised their price target on shares of Imperva from $55.00 to $57.00 and gave the stock a “buy” rating in a research report on Friday, July 28th. Piper Jaffray Companies set a $58.00 price target on shares of Imperva and gave the stock a “buy” rating in a research report on Monday, August 28th. Royal Bank Of Canada reissued a “buy” rating and set a $49.00 price target on shares of Imperva in a research report on Wednesday, October 18th. Finally, Oppenheimer Holdings, Inc. reissued a “buy” rating and set a $55.00 price target on shares of Imperva in a research report on Thursday, November 9th.

Shares of Imperva (IMPV) traded down $0.60 during trading on Friday, reaching $40.20. 331,828 shares of the company’s stock traded hands, compared to its average volume of 338,511. Imperva has a one year low of $35.45 and a one year high of $52.40.

Imperva (NASDAQ:IMPV) last announced its quarterly earnings data on Wednesday, November 8th. The software maker reported $0.33 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.22 by $0.11. The firm had revenue of $83.89 million during the quarter, compared to analyst estimates of $83.79 million. Imperva had a net margin of 3.04% and a negative return on equity of 8.52%. Imperva’s revenue was up 22.6% on a year-over-year basis. During the same period last year, the firm posted $0.08 EPS. equities analysts anticipate that Imperva will post -0.52 earnings per share for the current year.

In related news, Director Anthony J. Bettencourt sold 99,598 shares of Imperva stock in a transaction on Thursday, August 24th. The shares were sold at an average price of $43.59, for a total value of $4,341,476.82. Following the sale, the director now owns 99,598 shares of the company’s stock, valued at approximately $4,341,476.82. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.90% of the stock is currently owned by company insiders.

A number of institutional investors and hedge funds have recently made changes to their positions in IMPV. SG Americas Securities LLC acquired a new stake in Imperva during the 3rd quarter worth $134,000. First Quadrant L P CA acquired a new stake in Imperva during the 3rd quarter worth $136,000. Ameritas Investment Partners Inc. boosted its stake in Imperva by 18.7% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 2,940 shares of the software maker’s stock worth $141,000 after purchasing an additional 464 shares during the last quarter. KCG Holdings Inc. acquired a new stake in Imperva during the 1st quarter worth $201,000. Finally, Migdal Insurance & Financial Holdings Ltd. boosted its stake in Imperva by 26.2% during the 2nd quarter. Migdal Insurance & Financial Holdings Ltd. now owns 4,177 shares of the software maker’s stock worth $201,000 after purchasing an additional 866 shares during the last quarter. 92.20% of the stock is currently owned by institutional investors.

COPYRIGHT VIOLATION WARNING: This story was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this story on another site, it was stolen and reposted in violation of US & international copyright legislation. The original version of this story can be read at https://www.dispatchtribunal.com/2017/12/05/imperva-inc-impv-receives-consensus-recommendation-of-hold-from-analysts.html.

About Imperva

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Analyst Recommendations for Imperva (NASDAQ:IMPV)

Receive News & Ratings for Imperva Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply